Aktiespot

Daewon Pharmaceutical Co., Ltd. (Daewonpharm) aksje

003220.KS

Stengt
₩11,240.00+2,590.00 (+29.94%)
Laster graf...

Daewonpharm

Åpning11,240.00
Høy11,240.00
Lav11,240.00
Volum69.97k
P/EN/A
Markedsverdi240.91B
52-ukers høy14,700.00
52-ukers lav8,070.00
Gj.sn. volum34.41k
Utbytte2.89%
Beta0.16
EPSN/A

Om Daewon Pharmaceutical Co., Ltd. (Daewonpharm) aksje

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa. The company was founded in 1958 and is headquartered in Seoul, South Korea.

Selskapsinformasjon

Børs: KSE (KSC)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
386 Cheonhodae-ro
Seoul, South Korea
Telefon: + 82 2 2204 7000

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
13,000.00
15.7%
Gjennomsnittlig kursmål
14,666.67
30.5%
Median kursmål
15,000.00
33.5%
Høyeste kursmål
16,000.00
42.3%

Andre ser også på: